New drugs to treat tuberculosis

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Tuberculosis (TB) has been a leading cause of death for more than a century. While effective therapies exist, treatment is long and cumbersome. Tuberculosis control is complicated by the overlapping problems created by global inadequacy of public health infrastructures, the interaction of the TB and human immunodeficiency virus epidemics, and the emergence of drug-resistant TB. After a long period of neglect, there is now significant progress in development of TB diagnostics and therapeutics. Focusing on treatment for active TB, we review the new pathways to TB regimen development, and the new and repurposed anti-TB agents in clinical development.

Original languageEnglish (US)
Article number12
JournalF1000 Medicine Reports
Volume4
Issue number1
DOIs
StatePublished - Jun 1 2012

Fingerprint

Tuberculosis
Pharmaceutical Preparations
Multidrug-Resistant Tuberculosis
Cause of Death
Public Health
HIV
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New drugs to treat tuberculosis. / Swindells, Susan.

In: F1000 Medicine Reports, Vol. 4, No. 1, 12, 01.06.2012.

Research output: Contribution to journalReview article

@article{b06b53c2f9344149b290ab755c998a43,
title = "New drugs to treat tuberculosis",
abstract = "Tuberculosis (TB) has been a leading cause of death for more than a century. While effective therapies exist, treatment is long and cumbersome. Tuberculosis control is complicated by the overlapping problems created by global inadequacy of public health infrastructures, the interaction of the TB and human immunodeficiency virus epidemics, and the emergence of drug-resistant TB. After a long period of neglect, there is now significant progress in development of TB diagnostics and therapeutics. Focusing on treatment for active TB, we review the new pathways to TB regimen development, and the new and repurposed anti-TB agents in clinical development.",
author = "Susan Swindells",
year = "2012",
month = "6",
day = "1",
doi = "10.3410/M4-12",
language = "English (US)",
volume = "4",
journal = "F1000 Medicine Reports",
issn = "1757-5931",
publisher = "Medicine Reports Limited",
number = "1",

}

TY - JOUR

T1 - New drugs to treat tuberculosis

AU - Swindells, Susan

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Tuberculosis (TB) has been a leading cause of death for more than a century. While effective therapies exist, treatment is long and cumbersome. Tuberculosis control is complicated by the overlapping problems created by global inadequacy of public health infrastructures, the interaction of the TB and human immunodeficiency virus epidemics, and the emergence of drug-resistant TB. After a long period of neglect, there is now significant progress in development of TB diagnostics and therapeutics. Focusing on treatment for active TB, we review the new pathways to TB regimen development, and the new and repurposed anti-TB agents in clinical development.

AB - Tuberculosis (TB) has been a leading cause of death for more than a century. While effective therapies exist, treatment is long and cumbersome. Tuberculosis control is complicated by the overlapping problems created by global inadequacy of public health infrastructures, the interaction of the TB and human immunodeficiency virus epidemics, and the emergence of drug-resistant TB. After a long period of neglect, there is now significant progress in development of TB diagnostics and therapeutics. Focusing on treatment for active TB, we review the new pathways to TB regimen development, and the new and repurposed anti-TB agents in clinical development.

UR - http://www.scopus.com/inward/record.url?scp=84862208520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862208520&partnerID=8YFLogxK

U2 - 10.3410/M4-12

DO - 10.3410/M4-12

M3 - Review article

VL - 4

JO - F1000 Medicine Reports

JF - F1000 Medicine Reports

SN - 1757-5931

IS - 1

M1 - 12

ER -